Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z

Галектин-3: одна молекула для алфавита заболеваний — от А до Я
Salvatore Sciacchitano, Luca Lavra, Alessandra Morgante, Alessandra Ulivieri, Fiorenza Magi, Gian De Francesco, Carlo Bellotti, Leila Salehi, Alberto Rícci
2018-01-26

Galectin-3cancer and fibrosisdiagnostic biomarkerprognostic biomarkertherapeutic target
Galectin-3 (Gal-3) regulates basic cellular functions such as cell-cell and cell-matrix interactions, growth, proliferation, differentiation, and inflammation. It is not surprising, therefore, that this protein is involved in the pathogenesis of many relevant human diseases, including cancer, fibrosis, chronic inflammation and scarring affecting many different tissues. The papers published in the literature have progressively increased in number during the last decades, testifying the great interest given to this protein by numerous researchers involved in many different clinical contexts. Considering the crucial role exerted by Gal-3 in many different clinical conditions, Gal-3 is emerging as a new diagnostic, prognostic biomarker and as a new promising therapeutic target. The current review aims to extensively examine the studies published so far on the role of Gal-3 in all the clinical conditions and diseases, listed in alphabetical order, where it was analyzed.
1
Galectin-3 is emerging as a diagnostic and prognostic biomarker and a promising therapeutic target.
2
Galectin-3 is implicated in the pathogenesis of cancer, fibrosis, chronic inflammation, and tissue scarring across multiple organs.
3
Galectin-3 regulates cell-cell and cell-matrix interactions, growth, proliferation, differentiation, and inflammation.
4
The expanding literature on Galectin-3 reflects broad research interest across diverse clinical contexts and diseases.
5
The review comprehensively examines Galectin-3 across clinical conditions and diseases, organized alphabetically from A to Z.

Galectin-3 (Gal-3) in human diseases and clinical conditions

The role, diagnostic and prognostic biomarker potential, and therapeutic-target relevance of Gal-3 across diseases, including cancer, fibrosis, chronic inflammation, and scarring

Publication Details
Publication Date
2018-01-26
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Salvatore Sciacchitano
Luca Lavra
Alessandra Morgante
Alessandra Ulivieri
Fiorenza Magi
Gian De Francesco
Carlo Bellotti
Leila Salehi
Alberto Rícci
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%